Log in

NASDAQ:MLAB - Mesa Laboratories Stock Price, Forecast & News

+3.39 (+1.38 %)
(As of 12/15/2019 04:00 PM ET)
Today's Range
Now: $249.53
50-Day Range
MA: $235.54
52-Week Range
Now: $249.53
Volume36,280 shs
Average Volume31,843 shs
Market Capitalization$1.09 billion
P/E Ratio46.47
Dividend Yield0.26%
Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. Read More…

Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
Current SymbolNASDAQ:MLAB



Sales & Book Value

Annual Sales$103.14 million
Cash Flow$8.14 per share
Book Value$28.77 per share


Net Income$7.48 million


Market Cap$1.09 billion
Next Earnings Date2/3/2020 (Estimated)
OptionableNot Optionable

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Tuesday, October 1st. Investors of record on Friday, November 29th will be paid a dividend of $0.16 per share on Monday, December 16th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date of this dividend is Wednesday, November 27th. View Mesa Laboratories' Dividend History.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) announced its earnings results on Wednesday, November, 6th. The medical instruments supplier reported $1.45 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $1.50 by $0.05. The medical instruments supplier earned $25.54 million during the quarter, compared to the consensus estimate of $26 million. Mesa Laboratories had a net margin of 9.45% and a return on equity of 17.61%. View Mesa Laboratories' Earnings History.

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release their next quarterly earnings announcement on Monday, February 3rd 2020. View Earnings Estimates for Mesa Laboratories.

What price target have analysts set for MLAB?

3 brokerages have issued 1-year target prices for Mesa Laboratories' shares. Their forecasts range from $250.00 to $275.00. On average, they expect Mesa Laboratories' stock price to reach $262.50 in the next twelve months. This suggests a possible upside of 5.2% from the stock's current price. View Analyst Price Targets for Mesa Laboratories.

What is the consensus analysts' recommendation for Mesa Laboratories?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mesa Laboratories.

Has Mesa Laboratories been receiving favorable news coverage?

News articles about MLAB stock have been trending neutral recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Mesa Laboratories earned a daily sentiment score of 0.2 on InfoTrie's scale. They also gave news articles about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Mesa Laboratories.

Who are some of Mesa Laboratories' key competitors?

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Intel (INTC), Micron Technology (MU), Verizon Communications (VZ), Alibaba Group (BABA), Coupa Software (COUP), PepsiCo (PEP), Becton Dickinson and (BDX), Walt Disney (DIS) and Mcdonald's (MCD).

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the folowing people:
  • Mr. Gary M. Owens, CEO, Pres & Director (Age 51)
  • Mr. John V. Sakys, Chief Financial Officer, Chief Accounting Officer, Sec. & Treasurer (Age 50)
  • Mr. Gregory T. DiNoia, Sr. VP of Commercial Operations (Age 54)
  • Ms. Helene R. Leone, Gen. Counsel
  • Mr. Peter Jung, VP of Corp. Devel. & Strategy

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a number of of institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (10.34%), State Street Corp (3.32%), Russell Investments Group Ltd. (0.81%), Castleark Management LLC (0.74%), Man Group plc (0.48%) and Comerica Bank (0.47%). Company insiders that own Mesa Laboratories stock include David M Kelly, Evan Guillemin, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks, Robert V Dwyer and Seg Ventures, Llc. View Institutional Ownership Trends for Mesa Laboratories.

Which major investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including Kistler Tiffany Companies LLC, Conestoga Capital Advisors LLC, Teton Advisors Inc., Rice Hall James & Associates LLC, Navellier & Associates Inc, NEXT Financial Group Inc and Voya Investment Management LLC. Company insiders that have sold Mesa Laboratories company stock in the last year include David M Kelly, Evan Guillemin, John Bradley Schmieder and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.

Which major investors are buying Mesa Laboratories stock?

MLAB stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Castleark Management LLC, Man Group plc, 6 Meridian, SG Americas Securities LLC, Comerica Bank, Cadence Capital Management LLC and State Street Corp. View Insider Buying and Selling for Mesa Laboratories.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $249.53.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $1.09 billion and generates $103.14 million in revenue each year. The medical instruments supplier earns $7.48 million in net income (profit) each year or $5.37 on an earnings per share basis. Mesa Laboratories employs 366 workers across the globe.View Additional Information About Mesa Laboratories.

What is Mesa Laboratories' official website?

The official website for Mesa Laboratories is http://www.mesalabs.com/.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]

MarketBeat Community Rating for Mesa Laboratories (NASDAQ MLAB)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  195 (Vote Outperform)
Underperform Votes:  179 (Vote Underperform)
Total Votes:  374
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe MLAB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel